Clinical Trials Logo

Clinical Trial Summary

Newborn's renal function is difficult to assess and its physiology during the first days of life is still incompletely known. Studies suggest that the newborn almost completely reabsorbs creatinine during the first 48 to 72 hours of life, while at the same time it continues to produce its own creatinine. Therefore, the initial stock of creatinine at birth still increases through this production and the non or weak clearance. A better knowledge of renal physiopathology in newborns would allow to improve the therapeutic management of the infants, particularly in case of potential nephrotoxicity. No study has attempted to assess the increase in urinary creatinine excretion in neonates from a given time. Objectives: To show when urinary creatinine excretion in newborns is efficient. Results: this study mightr show an inflection point in urinary creatinine excretion illustrating the postnatal age when renal function becomes efficient.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05813730
Study type Interventional
Source Central Hospital, Nancy, France
Contact Jean-Michel HASCOET
Phone 0383342934
Email j.hascoet@chru-nancy.fr
Status Not yet recruiting
Phase N/A
Start date March 2024
Completion date December 2024

See also
  Status Clinical Trial Phase
Completed NCT01217736 - Direct Renin Inhibition and the Kidney Phase 1
Completed NCT04742816 - Renal Effects of Hormones/Biomarkers in Transgender PrEP Recipients Phase 4
Completed NCT01598987 - Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients. Phase 3
Completed NCT00992043 - Creatine Supplementation and Diabetes N/A
Recruiting NCT04334135 - The Influence of Mitochondrial-Derived Reactive Oxygen Species on Racial Disparities in Neurovascular Function N/A
Completed NCT04940260 - Soluble Factors and Renal Outcome in Preeclampsia
Recruiting NCT02288663 - Renal Function Assessment in the Elderly Using Plasma Creatinine Assay and Lean Body Mass Measurement N/A
Completed NCT01227213 - The Vascular and Metabolic Effects of Sunitinib in Patients With Metastatic Renal Cell Carcinoma N/A
Completed NCT03228563 - The Effect of Probiotics on Chronic Kidney Disease N/A
Completed NCT01680744 - The Effect of Therapeutic Hypothermia on Deceased Donor Renal Graft Outcomes - a Randomized Controlled Trial From the Region 5 Donor Management Goals Workgroup N/A
Completed NCT05179564 - Renal Function Assessment in Critically Ill Children N/A
Recruiting NCT05503147 - Sativex® and Gentamicin for Optimized Pharmagological Treatment in Older Patients (CanPan) Phase 1
Withdrawn NCT01802255 - Sevoflurane- Safety in Long-term Sedation Procedures Phase 3
Completed NCT01320722 - Study of Vitamin D and Uric Acid Lowering on Kidney and Blood Vessel Function N/A
Completed NCT01138241 - Tenofovir Renal Toxicity and Glomerular Filtration Rate (GFR) Validation
Completed NCT01925235 - Analysis of Remote-ischemic Preconditioning Effects on Kidney Function N/A
Completed NCT00634920 - Evaluation of Early Conversion to Everolimus From Cyclosporine in de Novo Renal Transplant Recipients Phase 4
Recruiting NCT03170739 - Effects of Dexmedetomidine and Dopamine on Renal Function After Major Surgery Phase 4
Completed NCT00117390 - Evaluation of the Optimal Technique for Determination of Renal Function of Critically Ill Patients N/A
Completed NCT03605810 - Study to Develop a Tool to Estimate the Kidney Function in Databases Without Laboratory Data